Revenue - Urogen Pharma Ltd (NASDAQ:URGN) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 14.4 USD 4.2%

Updated:

Urogen Pharma Ltd
Revenue

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

|

Adjust for Inflation

Urogen Pharma Ltd
Revenue Peer Comparison

CLGN

KMDA

B

BLRX

ENTX

B

BONS

Company		Revenue	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Urogen Pharma Ltd NASDAQ:URGN	Revenue $82.7m	CAGR 3-Years 91%	CAGR 5-Years 136%	CAGR 10-Years N/A
	Collplant Biotechnologies Ltd NASDAQ:CLGN	Revenue $11m	CAGR 3-Years 21%	CAGR 5-Years 17%	CAGR 10-Years N/A
	Kamada Ltd NASDAQ:KMDA	Revenue $142.5m	CAGR 3-Years 2%	CAGR 5-Years 4%	CAGR 10-Years 7%
B	BioLine RX Ltd TASE:BLRX	Revenue $4.8m	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
	Entera Bio Ltd NASDAQ:ENTX	Revenue $0	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
B	Bonus Biogroup Ltd TASE:BONS	Revenue ₪0	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A

Urogen Pharma Ltd
Revenue Breakdown

Total Revenue: 82.7m USD

100%

Jelmyto: 82.7m USD

100%

See Also

Based on the financial report for Dec 31, 2023, Urogen Pharma Ltd's Revenue amounts to 82.7m USD.

Over the last year, the Revenue growth was 29%. The average annual Revenue growth rates for Urogen Pharma Ltd have been 91% over the past three years , 136% over the past five years .

Join more than 133,400+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.